Bellerophon Therapeutics (BLPH) Institutional Ownership $0.05 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSustainabilityTrends Institutional Ownership Changes (13F Filings) for Bellerophon Therapeutics (NASDAQ:BLPH)CurrentInstitutional OwnershipPercentage10.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$183.02KNumber ofInstitutional Sellers(last 12 months)0 Get BLPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLPH Institutional Buying and Selling by Quarter Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Bellerophon Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/7/2023Acadian Asset Management LLC265,253$182K0.0%N/A2.538% 11/17/2022Telemetry Investments L.L.C.47,500$52K0.1%-31.2%0.497% 7/26/2022Sepio Capital LP23,800$29K0.0%N/A0.249% 11/16/2021Telemetry Investments L.L.C.85,500$347K0.5%-6.0%0.899% 11/12/2021Renaissance Technologies LLC201,706$819K0.0%-21.5%2.122% 11/9/2021BlackRock Inc.120,620$490K0.0%+3.6%1.268% Get the Latest News and Ratings for BLPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellerophon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/17/2021Virtu Financial LLC16,495$80K0.0%N/A0.174% 8/16/2021Telemetry Investments L.L.C.90,920$440K0.6%+48.9%0.956% 8/16/2021State Street Corp21,027$102K0.0%-63.1%0.221% 8/13/2021Renaissance Technologies LLC257,072$1.24M0.0%+10.0%2.704% 8/13/2021Northern Trust Corp36,555$177K0.0%-51.6%0.385% 8/13/2021Geode Capital Management LLC58,380$282K0.0%-8.0%0.614% 8/13/2021Vanguard Group Inc.336,966$1.63M0.0%-6.2%3.545% 8/12/2021JPMorgan Chase & Co.6,507$31K0.0%+242.5%0.068% 8/12/2021Ergoteles LLC13,800$67K0.0%N/A0.145% 5/21/2021Citadel Advisors LLC20,000$104K0.0%N/A0.210% 5/19/2021Squarepoint Ops LLC14,569$76K0.0%N/A0.153% 5/18/2021New Mountain Vantage Advisers L.L.C.252,650$3.16M0.1%-75.0%2.658% 5/18/2021Tudor Investment Corp Et Al20,000$104K0.0%N/A0.210% 5/18/2021Citadel Advisors LLC20,000$104K0.0%N/A0.210% 5/17/2021 Caas Capital Management LP97,900$508K0.0%N/A1.030% 5/14/2021Laurion Capital Management LP20,000$104K0.0%N/A0.210% 5/13/2021Renaissance Technologies LLC233,799$1.21M0.0%+9.1%2.459% 5/12/2021Northern Trust Corp75,579$393K0.0%-15.7%0.795% 5/11/2021Element Capital Management LLC11,646$60K0.0%N/A0.123% 5/10/2021GSA Capital Partners LLP63,566$330K0.1%+6.7%0.669% 5/7/2021BlackRock Inc.321,782$1.67M0.0%+2.3%3.385% 4/28/2021DAVENPORT & Co LLC98,975$514K0.0%+10.9%1.041% 2/19/2021JPMorgan Chase & Co.10,701$72K0.0%+261.4%0.113% 2/12/2021LPL Financial LLC10,080$67K0.0%N/A0.106% 2/11/2021Northern Trust Corp89,607$598K0.0%-2.8%0.943% 2/10/2021Renaissance Technologies LLC214,299$1.43M0.0%-13.7%2.256% 2/9/2021Wells Fargo & Company MN202,330$1.35M0.0%+83.5%2.130% 2/5/2021BlackRock Inc.314,617$2.10M0.0%+9.8%3.312% 2/4/2021GSA Capital Partners LLP59,589$397K0.1%+112.1%0.627% 11/16/2020AQR Capital Management LLC34,071$347K0.0%N/A0.359% 11/10/2020State Street Corp59,077$601K0.0%+82.9%0.622% 11/6/2020GSA Capital Partners LLP28,092$286K0.0%N/A0.296% 11/5/2020First Trust Advisors LP20,415$208K0.0%N/A0.215% 11/5/2020Wells Fargo & Company MN110,236$1.12M0.0%+6,163.4%1.161% Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.10/30/2020WINTON GROUP Ltd12,498$127K0.0%N/A0.132% 10/15/2020DAVENPORT & Co LLC94,475$962K0.0%-11.8%0.994% 8/25/2020Nuveen Asset Management LLC21,592$271K0.0%N/A0.227% 8/20/2020Charles Schwab Investment Management Inc.11,586$146K0.0%N/A0.122% 8/14/2020Bank of America Corp DE6,501$82K0.0%+49,907.7%0.068% 8/14/2020Telemetry Investments L.L.C.125,000$1.57M4.3%+150.0%1.316% 8/12/2020American International Group Inc.2,105$26K0.0%N/A0.022% 8/12/2020Tocqueville Asset Management L.P.25,400$319K0.0%+124.8%0.267% 8/7/2020New York State Common Retirement Fund8,000$100K0.0%N/A0.084% 7/28/2020DAVENPORT & Co LLC107,150$1.35M0.0%N/A1.128% 5/15/2020Morgan Stanley2,633$29K0.0%+426.6%0.043% (Data available from 1/1/2016 forward) BLPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Bellerophon Therapeutics shares: Acadian Asset Management LLC ($182K), Telemetry Investments L.L.C. ($52K).Learn more on BLPH's institutional investors. What percentage of Bellerophon Therapeutics stock is owned by institutional investors? 10.61% of Bellerophon Therapeutics stock is owned by institutional investors. Learn more on BLPH's institutional investor holdings. Which institutional investors have been buying Bellerophon Therapeutics stock? The following institutional investors have purchased Bellerophon Therapeutics stock in the last 24 months: Acadian Asset Management LLC ($265.25K). How much institutional buying is happening at Bellerophon Therapeutics? Institutional investors have bought a total of 265,253 shares in the last 24 months. This purchase volume represents approximately $183.02K in transactions. Which Bellerophon Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Bellerophon Therapeutics stock in the last 24 months: Telemetry Investments L.L.C. ($21.50K). How much institutional selling is happening at Bellerophon Therapeutics? Institutional investors have sold a total of 21,500 shares in the last 24 months. This volume of shares sold represents approximately $23.44K in transactions. Related Companies: NLS Pharmaceutics Major Shareholders InMed Pharmaceuticals Major Shareholders Phio Pharmaceuticals Major Shareholders NovaBay Pharmaceuticals Major Shareholders ASLAN Pharmaceuticals Major Shareholders Virpax Pharmaceuticals Major Shareholders Altamira Therapeutics Major Shareholders 180 Life Sciences Major Shareholders Tonix Pharmaceuticals Major Shareholders CNS Pharmaceuticals Major Shareholders This page (NASDAQ:BLPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellerophon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.